Search This Blog

Wednesday, August 3, 2016

Amgen And Advaxis Enter Global Cancer Immunotherapies Collaboration

Collaboration Will Advance Highly Targeted, Patient-Specific Treatment Approach
Advaxis Will Hold a Teleconference at 9:30 a.m. ET Today


Amgen - Investors - RSS Content

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.